• Entera Bio named former Gilead EVP Laura Hamill to its board, effective Dec. 1, 2026.
• Hamill brings 35+ years in global commercial leadership, most recently running Gilead’s worldwide commercial operations.
• She replaces Yonatan Malca, who is stepping down from the board.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entera Bio Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178913-26-004720), on October 06, 2026, and is solely responsible for the information contained therein.